semaglutide compounding fda issues warning about some compounded versions of for diabetes, weight loss BreezeMeds Reviewed: 2026 Consumer Report

A vial touching the back wall can experience localized freezing that destroys the peptide in that portion of the solution

Another large-scale cohort study demonstrated that long-term GLP-1RA use was associated with a more than twofold, exposure-dependent increase in the risk of developing nAMD

doi:10.1089/pho.2013.3616

Clinical studies have demonstrated that Semaglutide GLP-1 can lead to considerable weight loss when paired with a nutritious diet and consistent exercise

Advise patients that changes in insulin regimen can predispose to hyperglycemia or hypoglycemia and that changes in insulin regimen should be made under close medical supervision [see WARNINGS AND PRECAUTIONS ]

You can expect to see data from a late-stage trial of retatrutide later this year, a few months earlier than Eli Lilly anticipated.